Concepedia

Christopher Cow

CC

9

Publications

235

Citations

9

H-Index

1997

Active since

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Christopher Cow is an author at Genomics Institute of the Novartis Research Foundation specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyBiochemistryMolecular PharmacologyNatural SciencesChemistryEngineeringOrganic Chemistry

Publications per year

1997–2019

9

Publications

9

Antiviral activity of arylnaphthalene and aryldihydronaphthalene lignans

Christopher Cow, Carmen Oi Ning Leung, James L. Charlton · Canadian Journal of Chemistry · 2000 · 59 citations

Classic Stobbe Condensation, Large Scale Synthesis, Antiviral Activity +10

Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-Activated Receptor δ Agonists

Robert Epple, Christopher Cow, Xie Yongping et al. · Journal of Medicinal Chemistry · 2009 · 42 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +13

3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists. Part 2

Robert Epple, Mihai Azimioara, Ross Russo et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 29 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +7

3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists: Part 1

Robert Epple, Ross Russo, Mihai Azimioara et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 24 citations

Molecular Pharmacology, Part 1, Medicine +6

Synthesis of the fatty acid of pramanicin

Christopher Cow, David Valentini, Paul Harrison · Canadian Journal of Chemistry · 1997 · 23 citations

Diversity Oriented Synthesis, Biosynthesis, Bioorganic Chemistry +11

Rows per page

1–5 of 9